CryoLife, Inc. (CRY)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1655 ROBERTS BOULEVARD N W KENNESAW, GA 30144

CryoLife preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. Co. distributes human tissue including the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch tissue, both processed using its proprietary SynerGraft technology. Co.'s surgical sealants and hemostats include BioGlue Surgical Adhesive, BioFoam Surgical Matrix, and PerClot, an absorbable powdered hemostat. Through its subsidiary Cardiogenesis Corporation, Co. provides treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina.

Data based on most recent fiscal year report
Market Cap655.816 Million Shares Outstanding33.46 Million Avg Volume233.635 Thousand
1-Yr BETA vs S&P TR1.08 Current Ratio4.18 Quick Ratio3.09
View SEC Filings from CRY instead.
Q4 2018 All Institutions Hedge Funds 1
To trade CRY now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 141 13 (1.3%)
Aggregate 13F shares on 12/31/2018: 24.811 Million 1.055 Million
Aggregate 13F shares on 09/30/2018: 26.173 Million 1.1 Million
Percent change: -5.20% -4.06%
Funds creating new positions: 29 5
Funds Adding to an existing position: 52 3
Funds closing out their position: 18 5
Funds reducing their position: 37 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SIMPSON MICHAEL S SVP, REGULATORY AFFAIRS AND QA

  • Officer
11,022 2018-12-03 1

DAVIS JOHN E SENIOR VP, GLOBAL SALES

  • Officer
49,231 2018-09-18 13

HOLLOWAY JEAN F VP, GENERAL COUNSEL

  • Officer
53,385 2018-09-10 10

RONALD C ELKINS

  • Director
64,843 2018-09-05 8

CAPPS SCOTT B VP, CLINICAL RESEARCH

  • Officer
141,087 2018-08-30 5

MACKIN JAMES P PRESIDENT & CEO

  • Officer
243,298 2018-08-28 8

LEE DAVID ASHLEY EXECUTIVE VP, COO & CFO

  • Officer
279,732 2018-08-15 7

MORGAN HARVEY

  • Director
81,237 2018-08-13 2

HORTON AMY VP, CHIEF ACCOUNTING OFFICER

  • Officer
97,453 2018-08-10 7

MCCALL RONALD D

  • Director
159,899 2018-08-09 5

BORGSTROM MARNA P

  • Director
3,456 2018-08-09 2

SAURINI SHERRY M VP, QUALITY

  • Officer
26,274 2018-06-30 2

MCDERMID JAMES M SVP, CHRO

  • Officer
22,518 2018-06-30 3

SALVESON JON W

  • Director
0 2018-05-25 1

MAIER DENNIS B VICE PRESIDENT, OPERATIONS

  • Officer
9,130 2018-05-25 1

BOGENSCHUETZ THOMAS J VP, EMEA & GENERAL MANAGER

  • Officer
13,306 2018-05-25 1

BEVEVINO DANIEL J

  • Director
103,987 2018-05-23 1

ACKERMAN THOMAS F

  • Director
103,987 2018-05-23 1

BULLOCK JAMES

  • Director
12,904 2018-05-23 1

BURBANK JEFFREY H

  • Director
8,164 2018-05-23 1

MATTHEWS WILLIAM ROBERT SENIOR VP, OPERATIONS, QUALITY

  • Officer
39,883 2018-03-05 2

GALE DAVID C VP, RESEARCH & DEVELOPMENT

  • Officer
77,135 2017-11-16 0

BENSON JAMES

  • Director
54,086 2017-10-02 0

ANDERSON STEVEN G FORMER EXECUTIVE CHAIRMAN

  • Officer
No longer subject to file 2015-04-09 0

FRONK DAVID VP, REGULATORY AFFAIRS

  • Officer
110,559 2015-03-07 0

ANDERSON BRUCE G. VP, US SALES &GLOBAL MARKETING

  • Officer
104,096 2015-03-07 0

LANG DAVID P. VP, INT'L SALES & MARKETING

  • Officer
73,441 2015-02-26 0

BURRIS JEFFREY W VICE PRESIDENT & GEN. COUNSEL

  • Officer
95,221 2014-08-15 0

SEERY GERALD B SR. VP, SALES AND MARKETING

  • Officer
71,999 2012-11-30 0

HEACOX ALBERT E SR. VP RESEARCH AND DEVL

  • Officer
No longer subject to file 2011-12-31 0

COOK JOHN M

  • Director
104,500 2009-06-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments